MisraM, KatzmanD, MillerKK, et al.Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res, 2011; 26:2430–2438.
2.
National Institute for Health and Care Excellence. Eating disorders: Recognition and treatment. NICE guideline NG69. Available at: https://www.nice.org.uk/guidance/ng69 Accessed October20, 2019.
3.
MaïmounL, RenardE, LefebvreP, et al.Oral contraceptives partially protect from bone loss in young women with anorexia nervosa. Fertil Steril, 2019; 111:1020–1029.
4.
GoldenNH, LanzkowskyL, SchebendachJ, PalestroCJ, JacobsonMS, ShenkerIR. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol, 2002; 15:135–143.
5.
MisraM, KatzmanD, MillerKK, et al.Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res, 2011; 26:2430–2438.
6.
GordonCM, AckermanKE, BergaSL, et al.Functional hypothalamic amenorrhea: An endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2017; 102:1413–1439.
7.
BarrionuevoP, KapoorE, AsiN, et al.Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: A network meta-analysis. J Clin Endocrinol Metab, 2019; 104:1623–1630.
8.
BarrionuevoP, GionfriddoMR, Castaneda-GuarderasA, et al.Women's values and preferences regarding osteoporosis treatments: A systematic review. J Clin Endocrinol Metab, 2019; 104:1631–1636.
9.
CummingsSR, CosmanF, LewieckiEM, et al.Goal-directed treatment for osteoporosis: A progress report from the ASBMR-NOF working group on goal-directed treatment for osteoporosis. J Bone Miner Res, 2017; 32:3–10.
10.
MillerPD, HattersleyG, RiisBJ, et al.Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: A randomized clinical trial. JAMA, 2016; 316:722–733.
11.
CosmanF, CrittendenDB, AdachiJD, et al.Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med, 2016; 375:1532–1543.
12.
SaagKG, PetersenJ, BrandiML, et al.Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med, 2017; 377:1417–1427.
